clindamycin has been researched along with EHS Tumor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W | 1 |
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W; van der Waaij, D | 1 |
2 other study(ies) available for clindamycin and EHS Tumor
Article | Year |
---|---|
Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumor.
Topics: Animals; Cefotaxime; Cell Line; Clindamycin; Cytotoxicity, Immunologic; Killer Cells, Natural; Lung Neoplasms; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin; Sarcoma, Experimental | 1984 |
Antibiotic treatment, intestinal aerobic microflora and experimental sarcoma L-1 growth in Balb/c-mice.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cell Division; Clindamycin; Enterobacteriaceae; Escherichia coli; Gentamicins; Intestines; Mezlocillin; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Piperacillin; Sarcoma, Experimental | 1987 |